CTSO
CTSO
NASDAQ · Health Care

Cytosorbents Corp

$0.67
+0.04 (+6.62%)
As of Feb 8, 2:19 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 14.29M 13.44M 11.40M
Net Income 830.0K 783.9K 740.1K
EPS
Profit Margin 5.8% 5.8% 6.5%
Rev Growth +0.2% -9.4% -6.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 10.22M 11.74M 10.77M
Total Equity 24.01M 22.15M 20.33M
D/E Ratio 0.43 0.53 0.53
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.63M 1.54M 1.35M
Free Cash Flow 1.33M 1.21M 903.7K